Posts in CDMO

Illustration of the supply chain for targeted alpha therapy in Japan using Astatine-211. The graphic shows domestic cyclotron production, GMP radiochemistry and automated purification, a national site network strategy, time-critical logistics across Japan due to the 7.2-hour half-life, and outpatient administration of the radiopharmaceutical.
by Stefan Sandström
March 9, 2026

Targeted Alpha Therapy in Japan: why Domestic ²¹¹At Supply Matters for Scale

Radioligand therapy is now a board-level topic in Japan, not because the science is new, but […]
0
read more
Abstract illustration of Toronto’s biomedical innovation cluster centered on MaRS, research institutes, and startups.
by Stefan Sandström
December 2, 2025

MaRS and Beyond: How Toronto Engineered a Biomedical Growth Engine

Something quietly extraordinary has been happening in the heart of downtown Toronto. Within one of the […]
0
read more
Abstract landscape of sand-toned islands linked by light-blue channels, with dark-blue bio-factory shapes and red markers suggesting biologics flow across Japanese hubs.
by Stefan Sandström
October 14, 2025

Japan’s Biotech Surge: How You Can Convert the Startup Boom into Revenue

A New Order is taking shape in Japan’s life sciences. Conference floors are packed, university benches […]
0
read more
Illustration of a rejected pharmaceutical batch for import into Japan.
by Stefan Sandström
November 10, 2024

The Essential Guide for Successful Batch Release in Japan

Japan represents one of the world’s most demanding pharmaceutical markets, with rigorous quality standards that go […]
0
read more